ADRi Event: “Achieving a Nation Free of Cervical Cancer: Launch of the Philippine Cervical Cancer Elimination Movement”

Aligned with strategies and recommendations, there is a need for the country to scale up the implementation of evidence-based and cost-effective interventions. This forum gathered key stakeholders to discuss evidence-based and cost-effective interventions that will scale up the elimination of cervical cancer in the Philippines and to officially launch the Zero Cervical Cancer Movement. Read More

ADRi Event: Modernizing Philippine Defense Capabilities and Elevating Security Partnerships”

The current geopolitical landscape in the Indo-Pacific challenges states to continuously improve their defense capabilities to ensure a free and open region. The peace, security, and stability of the region lie in each state’s commitment to uphold and protect international laws, treaties, and policies in the promotion of a rules-based international order.

For its part, the Philippines remains committed to strengthen its defense capabilities by modernizing its military assets to secure its territorial integrity and contribute to the region’s security framework. The complex and evolving nature of internal and external challenges, particularly in the West Philippine Sea, require recalibrating defense strategies, capacitating of human resources, and capitalizing on existing and new security partnerships with like-minded allies such as the United States. Read More

ADRi Event: “Sustaining Gains and Balancing Priorities: Implementation of Rare Disease Act for 2023”

In line with the celebration of Rare Disease Week and the 7th year celebration of the signing of the Rare Disease Act of 2016, the Stratbase ADR Institute, in partnership with PSOD and UHCWatch, organized another dialogue entitled, “Sustaining Gains and Balancing Priorities: Implementation of Rare Disease Act for 2023”, to continue the discussion on plans that will benefit the RD patients.

The discussion aimed to provide a venue for key decision makers and stakeholders to continue the previous discussions that will further institutionalize the government’s support to rare disease patients, which is aligned with the implementation of the Rare Disease Law and in accordance with the achievement of the objectives of the IRDMSP 2022-2026. Read More